IndiaMart
FIEO
GHRP-2 Acetate 5mg is a synthetic peptide that acts as a Growth Hormone Releasing Peptide (GHRP), stimulating the pituitary gland to release growth hormone (GH). It is widely used in research on endocrine function, muscle development, metabolism, and tissue regeneration.
GHRP-2 Acetate is known for enhancing GH pulsatility, which supports muscle growth, fat metabolism, and cellular repair in experimental studies. Researchers use GHRP-2 Acetate 5mg to investigate growth hormone-related pathways, metabolic regulation, and age-related decline in GH levels. Its selective mechanism makes it a critical peptide in biomedical and pharmaceutical research.
BLUEPILL EXPRESS, a globally recognized merchant exporter, supplies GHRP-2 Acetate 5mg manufactured in GMP-certified facilities in India and China, based on client requirements. Each batch is verified for purity, stability, and bioactivity using HPLC and mass spectrometry, ensuring research-grade consistency suitable for international distribution.
Key Features of GHRP-2 Acetate 5mg:
- High-purity growth hormone releasing peptide (GHRP) for research applications
- Stimulates pituitary GH release for muscle, metabolism, and regenerative studies
- Investigates endocrine pathways, fat metabolism, and tissue repair
- Manufactured in GMP-certified facilities in India and China
- Supplied globally by BLUEPILL EXPRESS – Merchant Exporter
- Delivered with COA, MSDS, and full export documentation
- Available in bulk, OEM, and private-label formats
- Ideal for pharmaceutical, biomedical, and endocrine research
- Verified for bioactivity, purity, and consistent research-grade quality
As a trusted merchant exporter, BLUEPILL EXPRESS specializes in research peptides, bioactive molecules, and pharmaceutical-grade compounds, including GHRP-2 Acetate 5mg, GHRP-6, Ipamorelin, CJC-1295, GHK-Cu, and Semaglutide. With manufacturing facilities in India and China, BLUEPILL EXPRESS ensures custom production, regulatory compliance, and reliable global shipping for research institutions, biotech firms, and pharmaceutical developers worldwide.
